AbbVie Creates New Unit Allergan Aesthetics Upon Deal Close

Jan. 8, 2020, 1:12 PM UTC

AbbVie announced the creation of a new business, Allergan Aesthetics and the proposed leadership team for the combined company, effective upon the expected 1Q close of the Allergan acquisition.

  • AbbVie CEO Richard Gonzalez to be Chairman and CEO of combined company
  • Carrie Strom to be SVP, AbbVie, and President, Global Allergan Aesthetics

To view the source of this information click here

To contact the reporter on this story:
Yueqi Yang in New York at yyang492@bloomberg.net

To contact the editor responsible for this story:
Polina Noskova at pnoskova@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.